周一公布的一项研究显示，由于癌症发病率存在差异，2024年欧盟各国估计出现了近3万例额外的肺癌和宫颈癌病例，部分国家的发病率比其他一些国家高出七倍以上。
The incidence of nearly 30,000 additional cases of lung and cervical cancer was estimated across EU countries in 2024 due to disparities in cancer incidence rates, with some countries seeing rates more than seven times higher than others, according to a study presented Monday.
据安莎通讯社报道，意大利流行病学家迭戈·塞拉伊诺在马德里举行的欧洲肿瘤内科学会大会上公布了这一研究结果。
The findings were presented at the European Society for Medical Oncology Congress in Madrid by Italian epidemiologist Diego Serraino, the ANSA news agency reported.
该研究基于欧洲癌症信息系统（ECIS）的估算数据，在发病率超过欧盟平均水平的国家中识别出29412例超额病例。
Based on European Cancer Information System estimates, the study identified 29,412 excess cases in countries where incidence exceeded the EU average.
在男性肺癌方面，发病率从瑞典的每10万人38例到匈牙利的130例不等，12个国家共出现11105例超额病例。
For lung cancer among men, incidence ranged from 38 cases per 100,000 people in Sweden to 130 in Hungary, with 11,105 excess cases seen across 12 countries.
在女性方面，丹麦每10万人中有83例肺癌病例，而立陶宛为20例，11个国家因此出现13441例超额病例。
Among women, Denmark saw 83 lung cancer cases per 100,000 compared with 20 in Lithuania, contributing to 13,441 excess cases across 11 countries.
宫颈癌的差异更为显著，罗马尼亚每10万名女性中有36例，而岛国马耳他仅为5例。
Cervical cancer showed even greater disparities, with Romania seeing 36 cases per 100,000 women compared with just five on the island nation of Malta.
在10个国家发现的4866例超额宫颈癌病例中，罗马尼亚占2475例。
Of the 4,866 excess cervical cancer cases identified across 10 countries, Romania accounted for 2,475.
研究人员强调，应加强反吸烟措施以降低肺癌风险，同时通过接种人乳头瘤病毒（HPV）疫苗和定期筛查来预防宫颈癌并及早发现癌前病变。
Researchers emphasized stronger anti-smoking measures to reduce lung cancer risks, alongside human papillomavirus (HPV) vaccination, and regular screening to prevent cervical cancer and detect precancerous lesions early.